Swell in Off-Label Antipsychotic Prescribing 'Not Harmless'
A growing trend of off-label, low-dose antipsychotic prescribing to treat disorders such as anxiety and insomnia has been tied to an increased risk of cardiometabolic death.
United States Roger Mcintyre Jonas Berge University Of Toronto Journal Of Psychiatric Research Lund University
Source: medscape.com